MAPT and tauopathy: While AT180 (phospho-Thr231) is also linked to early tau pathology (Barthélemy et al., 2020), it may be mediated by distinct kinases (e.g., CDK5), which could be differentially affected by IL-1RAcP deficiency in a model of LPS-induced tauopathy.